- Home
- MTLS
MTLS
Materialise NV
as 03-28-2025 4:00pm EST
| Founded: | 1990 | Country: | Belgium |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 2014 |
| Target Price: | $9.50 | AVG Volume (30 days): | 215.0K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.24 | EPS Growth: | 106.79 |
| 52 Week Low/High: | $4.70 - $9.69 | Next Earning Date: | 04-24-2025 |
| Revenue: | $276,182,835 | Revenue Growth: | 4.15% |
| Revenue Growth (this year): | 6.55% | Revenue Growth (next year): | 9.21% |
Latest Materialise NV News
MTLS Breaking Stock News: Dive into MTLS Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
Are Materialise NV's (NASDAQ:MTLS) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Simply Wall St.
17 days ago
US Market's Undiscovered Gems Including 3 Promising Small Caps
Simply Wall St.
20 days ago
Undervalued Small Caps With Insider Action To Watch In March 2025
Simply Wall St.
25 days ago
Non-Executive Chairman of Materialise Picks Up 40% More Stock
Insider Monkey
a month ago
Materialise NV (MTLS): A Bull Case Theory
Simply Wall St.
a month ago
Materialise NV Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Simply Wall St.
a month ago
Materialise Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
GuruFocus.com
a month ago
Materialise NV (MTLS) Q4 2024 Earnings Call Highlights: Record Medical Revenue Amid ...
Compare MTLS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MTLS Materialise NV - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.